<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-pharmaceutics-13-00387">
 <label>43.</label>
 <element-citation publication-type="web">
  <person-group person-group-type="author">
   <collab>Committee for Medicinal Products for Human Use (CHMP)</collab>
  </person-group>
  <article-title>Reflection Paper: Formulations of Choice for the Paediatric Population Agreed by Paediatric Working Party &amp; Quality Working Party Adoption by Chmp for Release for Consultation End of Consultation (Deadline for Comments)</article-title>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://www.ema.europa.eu/en/formulations-choice-paediatric-population" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.ema.europa.eu/en/formulations-choice-paediatric-population</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-03-20">(accessed on 20 March 2020)</date-in-citation>
 </element-citation>
</ref>
